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Abstract
Background: Actinobaculum schaalii is a Gram-positive, facultative anaerobic coccoid rod, classified as a new genus
in 1997. It grows slowly and therefore is easily overgrown by other pathogens, which are often found
concomitantly. Since 1999, Actinobaculum schaalii is routinely investigated at our hospital, whenever its presence is
suspected due to the detection of minute grey colonies on blood agar plates and negative reactions for catalase.
The objective of this study was to determine the clinical significance of Actinobaculum schaalii, identified in our
microbiology laboratory over the last 11 years.
Methods: All consecutive isolates with Actinobaculum schaalii were obtained from the computerized database of
the clinical microbiology laboratory and patients whose cultures from any body site yielded this pathogen were
analyzed. Observation of tiny colonies of Gram-positive, catalase-negative coccoid rods triggered molecular
identification based on 16S rRNA gene sequencing.
Results: 40 isolates were obtained from 27 patients during the last 11 years. The patient’s median age was 81
(19-101) years, 25 (92.6%) had underlying diseases and 12 (44.4%) had a genitourinary tract pathology.
Actinobaculum schaalii was isolated in 12 urine cultures, 21 blood cultures, and 7 deep tissue biopsies. Twenty-five
(62.5%) specimens were monobacterial, the remaining 15 (37.5%) were polybacterial 7/7 deep tissue samples (three
bloodcultures and five urine cultures). Recovery from urine was interpreted as colonization in 5 (18.6%) cases
(41.6% of all urine samples). Six (22.2%) suffered from urinary tract infections, six (22.2%) from abscesses (skin,
intraabdominal, genitourinary tract, and surgical site infections) and 10 (37.0%) from bacteremia.
Conclusions: In this largest case series so far, detection of Actinobaculum schaalii was associated with an infection
- primarily sepsis and abscesses - in 81.5% of our patients. Since this pathogen is frequently part of polymicrobial
cultures (42.5%) it is often overlooked or considered a contaminant. Detection of Actinobaculum schaalii in clinical
isolates mainly reflects infection indicating that this Gram-positive rod is not an innocent bystander.
Background
Actinobaculum schaalii is a Gram-positive, facultative
anaerobic, nonmotile coccoid rod, classified as a new
genus in 1997 [1]. The genus Actinobaculum includes A.
schaalii, A. suis, A. massiliae, and A. urinale and is closely
related to the genera Actinomyces and Arcanobacterium
[1].
Actinobaculum schaalii grows slowly after 48 h in an
anaerobic atmosphere at 37°C as tiny grey colonies, less
than 1 mm in diameter, and shows weak b-hemolysis on
agar plates containing 5% horse or sheep blood. It is cata-
lase, oxidase, and urease negative and is easily overgrown
by other bacteria, which are often found concomitantly.
Because of its slow anaerobic growth and resemblance to
the normal bacterial flora on skin and mucosa, A. schaalii
is often overlooked or considered a contaminant. These
difficulties regarding detection and identification impede
evaluation of the clinical impact of this pathogen and of
its potential to cause invasive infection.
A. schaalii has been reported to be responsible for
urinary tract infections, mainly in elderly patients with
underlying urological predispositions [2-5]. It has also
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than urine such as blood, but its pathogenic potential
remains unknown.
Since 1999, A. schaalii is routinely screened at our
hospital. The objective of this study was to determine
the clinical significance of A. schaalii,i d e n t i f i e di no u r
microbiology laboratory over the last 11 years.
Methods
Setting
The University Hospital of Basel is an 855 bed tertiary care
center in Basel, Switzerland, with approximately 30’000
admissions per year. The study was approved by the local
ethics committee as part of the quality assurance program.
Patients and data collection
All consecutive isolates with A. schaalii were obtained
from the computerized database of the clinical microbiol-
ogy laboratory and patients whose cultures from any body
site yielded this pathogen were analyzed. A board certified
infectious diseases specialist then reviewed the medical
records of these patients and collected data regarding
patient demographic characteristics, underlying diseases or
condition, clinical manifestations at the time of detection
of A. schaalii, antibiotic therapy received, and clinical out-
come. Definite antibiotic treatment was defined as the anti-
biotic regimen chosen after identification of the pathogen
was completed. Presence of A. schaalii was categorized
into colonization and infection. Urinary tract infections,
surgical site infections, bloodstream infections, bone and
joint infections, intraabdominal infections, skin and soft tis-
sue infections, and upper and lower respiratory tract infec-
tions were defined according to the criteria of the Centers
for Disease Control and Prevention (CDC) [6].
Culture and Species Identification of Actinobaculum
schaalii
Grey, tiny colonies with weak b-hemolysis or without
hemolysis on 5% Columbia sheep blood agar after 48 h of
anaerobic or 5% CO2 incubation were further analyzed.
All isolates showing Gram-positive coccoid rods and a
negative catalase reaction were identified by partial 16S
RNA gene sequencing using Microseq 500 Bacterial Iden-
tification Kit (Applied Biosystems, Rotkreuz, Switzerland)
[7-9]. All bacteria growing in specimens supposed to be
sterile and monocultures from normally unsterile body-
sites were considered to be clinically relevant.
Blood cultures performed at the University Hospital
always involve cultivation in an aerobic and in an anae-
robic bottle.
Results
40 specimens with detection of A. schaalii were obtained
from 27 different patients during the last 11 years. The
patient’s median age was 81 (19-101) years, and there
was a slight male predominance (59.3%). Twenty-five
patients (92.6%) had underlying diseases, of which cardio-
pathy was most commonly encountered (14, 51.9%).
Twelve patients (44.4%) had a pathology of the genitour-
inary tract, mostly prostatic hyperplasia (5, 18.5%) and
five patients (18.5%) had an urinary catheter or a double-
J-catheter in place at the time of detection of A. schaalii.
Only one patient (3.7%) was receiving immunosuppres-
sive treatment due to renal transplantation (Table 1).
A. schaalii was detected in 21 blood cultures, 7 deep
tissue biopsies and 12 urine cultures. Its presence was
interpreted as colonization of the urinary tract without
Table 1 Baseline characteristics and outcome
Patient’s baseline characteristics (n = 27) and outcome
Age (years)
Mean 73
Median 81
Range 19-101
Gender
Male 16 (59.3%)
Female 11 (40.7%)
Hospitalstay (days)
Mean 18
Median 9
Range 1-79
Immunosuppression 1 (3.7%)
Comorbidities 25 (92.6%)
Cancer 7 (25.9%)
Cardiopathy 14 (51.9%)
Chronic renal insufficiency 4 (14.8%)
Diabetes mellitus 4 (14.8%)
Neurological disorder 13 (48.1%)
Hypertension 6 (22.2%)
Chronic pulmonary disorder 2 (7.4%)
Chronic Vascular disorder 4 (14.8%)
Endocriological disorder (other than diabtes mellitus 3 (11.1%)
Chronic pancreatitis 1 (3.7%)
Underlying genitourinary tract pathology 12 (44.4%)
Nephrolithiasis 1 (3.7%)
Stenosis 4 (14.8%)
Double-J catheter 2 (7.4%)
Urinary catheter 3 (11.1%)
Prostatic hyperplasia 5 (18.5%)
Renal cysts 1 (3.7%)
Uterine and vaginal prolapse 1 (3.7%)
Renal transplantation 1 (3.7%)
Outcome
Discharge 17 (63.0%)
Referal to another hospital 3 (11.1%)
Referal to a longterm-care facility 5 (18.5%)
Death 2 (7.4%)
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patients, accounting for 41.6% of all urine samples. Six
patients (22.2%) suffered from urinary tract infections,
six (22.2%) from abscesses (skin, intraabdominal, geni-
tourinary tract, and surgical site infections) and 10
(37.0%) from bacteremia (Table 2).
A. schaalii affected the genitourinary tract infections
in most cases (48.1%). The majority of patients (10/13,
76.9%) affected had underlying pathologies of the urin-
ary tract. In three patients with positive blood cultures,
diagnosed as urosepsis, Gram-positive rods (10
4-10
6
colonies per ml) were detected in urine cultures, how-
ever, weren’t further identified as these cultures were
polymicrobial. Abscesses of the genitourinary tract
involved the scrotum in one patient and the renal pelvis
in another (Table 2).
Surgical site infections occurred in two patients, one
after an operation involving the upper jaw, the other
after bladder-stone extraction.
Bacteremia with Actinobaculum schaalii was asso-
ciated with spondylodiscitis and pneumonia, in one case
respectively, with intraabdominal infection in three cases
and with urinary tract infections in 5 cases (Table 2). In
the patient with spondylodiscitis, Actinobaculum schaa-
lii was also detected in the CT-guided biopsy of the
disc. Underlying intraabdominal infections detected
were occlusive ileus and diverticulitis.
Twenty-three (57.5%) specimens were monobacterial,
the remaining 17 (42.5%) were polybacterial 7/7 deep
tissue samples, five blood cultures, and five urine cul-
tures (Table 3). In patients with polybacterial blood cul-
tures, the other pathogens detected were Pseudomonas
aeruginosa (P. aeruginosa i n2o f2a n dA. schaalii in 1
of 2 blood cultures) in a patient with urosepsis, Finegol-
dia magna (Finegoldia magna i n2o f2a n dA. schaalii
in 4 of 4 bloodcultures) in a patient with diverticulitis,
Clostridium clostridiforme and Bacteroides fragilis (both
i n1o f4a n dA. schaalii i n1o f4b l o o dc u l t u r e s )i na
patient with obstructive ileus and Veillonella (in 2 of 8
and A. schaalii in 8 of 8 bloodcultures) in a patient with
unclear intraabdominal infection. Of interest, the patient
with P. aeruginosa and A. schaalii in the blood culture,
also had Gram-positive rods (10
4 CFU/ml) and Gram-
negative rods (10
5 CFU/ml) in the urine culture, how-
ever, these weren’t further differentiated.
Six patients received no antibiotic treatment, in five of
which detection of A. schaalii was interpreted as coloni-
zation. The remaining patient suffered from an abscess
involving the skin, which was surgically drained. Most
patients were treated with amoxicillin/clavulanic acid
(10, 37.0%) followed by administration of a quinolone
(7, 25.9%).
Median duration of antibiotic treatment was 15.5 days
(range 3 to 84 days). The majority of patients could be
discharged (17, 63.0%), two (7.4%) patients died due to
metastatic carcinoma, the remaining were transferred to
another hospital (3, 11.1%) or to a long-term-care facil-
ity (5, 18.5%).
Discussion
A. schaalii caused an invasive infection in 81.5% of our
patients and its presence was interpreted as colonization
of the urinary tract in five patients. Infections of the
genitourinary tract were by far the most common mani-
festation of invasive disease. The ability of this pathogen
to cause urinary tract infections has also been reported
in the literature previously. Beguelin et al. described the
clinical features of 20 patients and found urinary tract
infections to be the most common manifestation (11/20,
55%) [10]. The authors further described a high rate of
underlying urinary tract pathology as detected in our
study. We detected A. schaalii in the blood cultures of
10 patients, only half of which were associated with
urinary tract infections. The majority of the remaining
Table 2 Distribution of infections and colonisation with Actinobaculum schaalii
Infections and colonisation with Actinobaculum schaalii (n = 27)
Bacteremia 10 (37.0%)
with urinary tract infection 5 (18.5%)
with intaabdominal infection 3 (11.1%)
with spondylodiscitis 1 (3.7%)
with pneumonia 1 (3.7%)
Abscess 6 (22.2%)
Abdominal 1 (3.7%)
Skin 1 (3.7%)
Surgical site infection (upper jaw and after bladder-stone extraction) 2 (7.4%)
Genitourinary tract 2 (7.4%)
Urinary tract infection 6 (22.2%)
with detection of A. schaalii in urine culture 6 (22.2%)
Colonisation (detection of A. schaalii in urine without clinical signs of infection) 5 (18.6%)
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one patient suffered from spondylodiscitis. Therefore,
detection of this pathogen in blood cultures should
prompt the clinician to search also for abdominal or
other foci if no association with the genitourinary tract
can be found.
Beguelin et al. described the results of antimicrobial
resistance testing in their study, although there are no
recognized minimal inhibitory concentration (MIC)
interpretative standards for A. schaalii [10]. They found
that most of their strains showed high MIC levels to
ciprofloxacin (>32 mg/L) and to trimethoprim/sulfa-
methoxazole (>32 mg/L), however, all of their 20 iso-
lated tested, showed low MIC level to beta-lactams (≤
0.19 for penicillin) [10]. Similar results were described
by Cattoir et al. after testing 48 clinical isolates [11].
The majority of our patients were treated with betalac-
tam-antibiotics, seven however, all with urinary tract
infections, were treated with quinolones, possibly with-
out in vitro activity. We therefore conclude, that suscep-
tebilty testing should be routinely performed, when A.
schaalii is detected in relevant clinical specimens and
interpretative standards for interpretation of MICs
should be developed. Empirically initiated treatment for
urinary tract infections often consists of quinolones or
trimethoprim/sulfamethoxazole and may therefore, not
be effective.
A. schaalii was often detected together with other bac-
teria (17 of 40 cultures, 42.5%), especially in urine cul-
tures (5 of 12, 41.7%) and in all abscesses (7 of 7, 100%).
In contrast, Beguelin et al. described a much lower rate
of polybacterial cultures, with 18 out of 21 (86%) speci-
mens being monobacterial [10]. As this pathogen is dif-
ficult to detect in the laboratory and is easily overgrown
by other bacteria, awareness of its existence is crucial as
not to underestimate its presence. Bank et al. analyzed
252 urine samples for presence of A. schaalii by a real-
time quantitative PCR they developed and found 41 of
252 samples (16%) to be positive with bacterial concen-
trations >10
4 CFU/mL [3]. Of 155 urine samples from
patients >60 years of age, 34 (22%) were PCR positive,
of which 31 (91%) - the vast majority - harbored other
common uropathogenic bacteria, in addition to
A. schaalii. In our study three patients with A. schaalii
in their blood cultures had Gram-positive rods (10
4-10
6
colonies per ml) in urine cultures drawn at the same
time, however, these weren’t further identified as cul-
tures were polymicrobial. One of the patients described
in our study with P. aeruginosa and A. schaalii in blood
cultures, also had Gram-positive rods (10
4/ml) and
Gram-negative rods (10
5/ml) in the urine culture drawn
at the same time. It is plausible that the pathogens detected
in the urine culture, were A. schaalii and P. aeruginosa,
respectively, demonstrating that A. schaalii has the ability
to invade the bloodstream even in the presence of a well-
known uro-pathogen as P. aeruginosa.
As our data demonstrate that this pathogen invaded
the bloodstream in the presence of other bacteria in
primary foci, we conclude that A. schaalii is not just
an innocent bystander, but has the potential to become
an invasive pathogen, leading to severe invasive infec-
tion as sepsis, spondylodiscitis [12], and endocarditis
[13].
Conclusions
In this largest case series so far, detection of Actinobacu-
lum schaalii was associated with an infection - primarily
sepsis and abscesses - in 81.5% of our patients. Since this
pathogen is frequently part of polymicrobial cultures
(42.5%) it is often overlooked or considered a contami-
nant. Detection of Actinobaculum schaalii in clinical
isolates mainly reflects infection indicating that this
Gram-positive rod is not an innocent bystander.
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Table 3 Distribution of monobacterial and polybacterial
isolates of Actinobaculum schaalii
Specimens with detection of Actinobaculum schaalii (n = 40)
monobacterial 23 (57.5%)
polybacterial 17 (42.5%)
Urine 12
monobacterial 7 (58.3%)
polybacterial 5 (41.7%)
Blood 21
monobacterial 16 (76.2%)
polybacterial 5 (23.8%)
Abscess 7
monobacterial 0 (0.0%)
polybacterial 7 (100.0%)
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